Capitol Health (ASX:CAJ) - 주가, 뉴스 및 분석

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

CAJ 주식 개요

Capitol Health Limited는 호주의 의료 시장에 진단 영상 장비 및 관련 서비스를 제공합니다.

CAJ 기본 분석
눈송이 점수
가치 평가	0/6
미래 성장	4/6
과거 실적	2/6
재무 상태	1/6
배당금	2/6

보상

수익은 매년 38.08% 증가할 것으로 예상됩니다.

올해부터 흑자전환

위험 분석

이자 지급액이 수익으로 잘 충당되지 않음

3.33% 의 배당금은 수익이나 현금 흐름으로 잘 감당되지 않습니다.

재무 결과에 영향을 미치는 대규모 일회성 항목

Capitol Health Limited 경쟁사

Australian Clinical Labs

ASX:ACL

AU$503.3m

Healthia

ASX:HLA

AU$252.1m

SILK Laser Australia

ASX:SLA

AU$177.4m

Apiam Animal Health

ASX:AHX

AU$62.6m

가격 내역 및 성능

다음에 대한 모든 사상 최고가, 변동 및 가격 하락 요약 Capitol Health
과거 주가
현재 주가	AU$0.32
52주 최고치	AU$0.32
52주 최저치	AU$0.18
베타	0.66
11개월 변경	28.57%
3개월 변경 사항	31.25%
1년 변경 사항	16.67%
33년 변화	-16.00%
5년 변화	28.57%
IPO 이후 변화	18.87%

최근 뉴스 및 업데이트

Calculating The Fair Value Of Capitol Health Limited (ASX:CAJ)

Jun 17

Recent updates

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 05

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Feb 14

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Jan 19

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Dec 22

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Dec 01

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Aug 17

Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Jul 25

Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Jul 04

주주 수익률

	CAJ	AU Healthcare	AU 마켓
7D	5.0%	-2.3%	-0.3%
1Y	16.7%	-20.2%	8.3%

수익률 대 산업: CAJ 지난 1년 동안 -19.2 %를 반환한 Australian Healthcare 산업을 초과했습니다.

수익률 대 시장: CAJ 지난 1년 동안 10.7 %를 반환한 Australian 시장을 초과했습니다.

가격 변동성

Is CAJ's price volatile compared to industry and market?
CAJ volatility
CAJ Average Weekly Movement	6.1%
Healthcare Industry Average Movement	5.4%
Market Average Movement	8.2%
10% most volatile stocks in AU Market	16.3%
10% least volatile stocks in AU Market	3.2%

안정적인 주가: CAJ 의 주가는 지난 3개월 동안 변동성이 심했습니다.

시간에 따른 변동성: CAJ 의 주간 변동성( 6% )은 지난 1년 동안 안정적인 모습을 보였습니다.

회사 소개

설립	직원	CEO	웹사이트
2005	1,000	Justin Walter	www.capitolhealth.com.au

Capitol Health Limited는 호주의 의료 시장에 진단 영상 장비 및 관련 서비스를 제공합니다. 이 회사는 일반 엑스레이, 자기공명영상, 초음파, 유방조영술, 도플러, 정형팬토모그램, 심장초음파, 컴퓨터 단층촬영, CT 혈관조영술, 콘빔 CT, 핵의학, 골밀도 측정, 형광 투시 검사 등 다양한 진단 영상 서비스를 제공합니다. 빅토리아, 태즈메이니아, 서호주, 남호주에서 캐피털 방사선과 브랜드뿐만 아니라 이미징 올림픽 파크, 방사선 태즈메이니아, 파울러 시몬스 방사선과, 여성 이미징, 다이렉트 방사선과, 퓨처 메디컬 이미징 그룹 브랜드 이름으로 다양한 클리닉을 운영했습니다.

Capitol Health Limited 기본 사항 요약

Capitol Health 의 수익과 매출은 시가총액과 어떻게 비교하나요?
CAJ 기본 통계
시가총액	AU$335.61m
수익(TTM)	AU$6.14m
수익(TTM)	AU$229.29m

54.6x

P/E 비율

1.5x

P/S 비율

CAJ 주가가 과대평가되어 있나요?

공정 가치 및 가치 분석 보기

수익 및 수익

최신 수익 보고서의 주요 수익성 통계(TTM)
CAJ 손익 계산서(TTM)
수익	AU$229.29m
수익 비용	AU$178.18m
총 이익	AU$51.11m
기타 비용	AU$44.97m
수익	AU$6.14m

최근 보고된 수익

Dec 31, 2023

다음 수익 날짜

n/a

주당 순이익(EPS)	0.0058
총 마진	22.29%
순이익 마진	2.68%
부채/자본 비율	62.0%

CAJ 의 장기적인 성과는 어땠나요?

과거 실적 및 비교 보기

배당금

3.2%

현재 배당 수익률

173%

지급 비율

CAJ 주식 개요

보상

위험 분석

Capitol Health Limited 경쟁사

ASX:ACL

AU$503.3m

ASX:HLA

AU$252.1m

ASX:SLA

AU$177.4m

ASX:AHX

AU$62.6m

가격 내역 및 성능

최근 뉴스 및 업데이트

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Calculating The Fair Value Of Capitol Health Limited (ASX:CAJ)

Now 21% undervalued after recent price drop

Now 21% undervalued

First half dividend of AU$0.005 announced

Recent updates

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Calculating The Fair Value Of Capitol Health Limited (ASX:CAJ)

Now 21% undervalued after recent price drop

Now 21% undervalued

First half dividend of AU$0.005 announced

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

New major risk - Financial position

Now 20% undervalued

Capitol Health Limited to Report First Half, 2024 Results on Feb 29, 2024

Capitol Health Limited Appoints Brendon Pentland as the Chief Financial Officer, Effective 1 April 2024

Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear

Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt

Now 21% undervalued

Now 21% undervalued after recent price drop

Capitol Health Limited Announces the Resignation of Craig Bremner as Chief Financial Officer

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased by 9.8% to AU$0.28

Capitol Health Limited, Annual General Meeting, Nov 15, 2023

Full year 2023 earnings: EPS misses analyst expectations

Capitol Health Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Price target decreased by 9.6% to AU$0.33

Capitol Health Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued

Now 21% undervalued

Capitol Health Limited (ASX:CAJ) completed the acquisition of Future Medical Imaging Group Pty Ltd.

Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?

Capitol Health Limited Declares Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Price target increased to AU$0.43

Capitol Health Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings: EPS misses analyst expectations

Capitol Health Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 October, 2022

Consensus EPS estimates fall by 12%

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Capitol Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 1, 2022

Capitol Health Limited to Report First Half, 2022 Results on Feb 24, 2022

Full year 2021 earnings released: EPS AU$0.012 (vs AU$0.001 in FY 2020)

Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly

Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Analysts increase EPS estimates to AU$0.012

First half 2021 earnings released: EPS AU$0.006 (vs AU$0.004 in 1H 2020)

Price target raised to AU$0.36

New 90-day high: AU$0.34

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Capitol Health Limited (ASX:CAJ) acquired Direct Radiology.

Capitol Health Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$0.28

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Price target raised to AU$0.31

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

Capitol Health Limited (ASX:CAJ) entered into a binding agreement to acquire Direct Radiology for AUD 12 million.

New 90-day high: AU$0.27

Capitol Health Limited Appoints Craig Bremner as Chief Financial Officer, November 9, 2020

Capitol Health Limited Announces Resignation of Marcell Judkins as Chief Financial Officer

Price target raised to AU$0.27